Vaccine Market By Vaccine Type (Live-Attenuated Vaccines, Inactivated Vaccines, Conjugate Vaccines, Toxoid Vaccines, mRNA Vaccines, DNA Vaccines, Viral Vector Vaccines, Other), By Route of Administration (Injectable Vaccines, Oral Vaccines, Nasal Vaccines), By Distribution Channel (Government Programs, Hospitals and Clinics, Pharmacies, Online Sales), By End-User (Hospitals and Clinics, Vaccination Centres, Research Institutes, Pharmaceutical Companies), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Feb 2025 | Report ID: MI1894 | 220 Pages


Report Coverage:

By Vaccine Type

  • Live-Attenuated Vaccines
  • Inactivated Vaccines
  • Conjugate Vaccines
  • Toxoid Vaccines
  • mRNA Vaccines
  • DNA Vaccines
  • Viral Vector Vaccines
  • Other

By Route of Administration

  • Injectable Vaccines
  • Oral Vaccines
  • Nasal Vaccines

By Distribution Channel

  • Government Programs
  • Hospitals and Clinics
  • Pharmacies
  • Online Sales

By End-User

  • Hospitals and Clinics
  • Vaccination Centres
  • Research Institutes
  • Pharmaceutical Companies

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of the Middle East & Africa

List of Companies:

  • Pfizer Inc.
  • BioNTech SE
  • Sinovac Biotech Ltd.
  • Moderna, Inc.
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Chongqing Zhifei Biological Products Co., Ltd.
  • AstraZeneca plc
  • Johnson & Johnson
  • Bavarian Nordic A/S
  • Inovio Pharmaceuticals, Inc.
  • Novavax, Inc.
  • Serum Institute of India Pvt. Ltd.
  • CSL Limited.

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.